Benign Hepatic Tumours

E. Biecker; H. P. Fischer; H. Strunk; T. Sauerbruch

doi:10.1055/s-2003-37316

Zeitschrift für Gastroenterologie, Table of Contents

Z Gastroenterol 2003; 41(2): 191-200
DOI: 10.1055/s-2003-37316

Übersicht

Benign Hepatic Tumours

Benigne LebertumorenE. Biecker¹ ^, ² , H. P. Fischer³ , H. Strunk⁴ , T. Sauerbruch¹

¹Medizinische Klinik und Poliklinik I, Universitätsklinikum Bonn
²Institut für klinische Pharmakologie, Universität Bern, Schweiz
³Institut für Pathologie, Universitätsklinikum Bonn
⁴Klinik für Radiologie, Universitätsklinikum Bonn

Abstract

Zusammenfassung

Gutartige Lebertumoren umfassen ein großes Spektrum von regenerativen und echt-neoplastischen Prozessen. Fortschritte in den bildgebenden Verfahren wie NMR, CT und Sonographie sowie verbesserte Möglichkeiten der histologischen Untersuchung durch den Einsatz immunhistochemischer Verfahren ermöglichen die richtige Diagnose bei den meisten Patienten. Laparotomie und Resektion sind daher oft zu vermeiden. Die Differenzialdiagnose zwischen fokal-nodulärer Hyperplasie und hepatozellulärem Adenom ist klinisch am wichtigsten, da es beim hepatozellulären Adenom zur Ruptur und Blutung kommen kann. Das kavernöse Hämangiom, der häufigste benigne Lebertumor, muss fast nie behandelt werden. Die Diagnose der nodulär-regenerativen Hyperplasie gestaltet sich häufig schwierig und die Patienten werden erst durch Zeichen und Komplikationen der portalen Hypertension auffällig. Das seltene Angiomyolipom muss nicht behandelt werden. Die Relevanz besteht in der Abgrenzung zu malignen Prozessen. Auch der inflammatorische Pseudotumor kann zu Verwechslungen mit malignen Geschehen Anlass geben, da die klinischen Zeichen wie z.B. eine B-Symptomatik sich häufig gleichen. Therapeutische Optionen sind die medikamentöse Therapie oder ein chirurgisches Vorgehen. Das kindliche benigne Hämangioendotheliom ist selten, kann aber lebensgefährliche Komplikationen verursachen. Das Gallengangsadenom ist häufig eine Zufallsdiagnose, der keine klinische Bedeutung zukommt, wohingegen das biliäre Zystadenom oft symptomatisch wird und aufgrund der möglichen malignen Entartung reseziert werden muss.

Abstract

Benign hepatic tumours include a broad spectrum of regenerative and true neoplastic processes. Due to advances in imaging procedures like MRI, CT-scan and ultrasound as well as progress in immunohistochemistry, the appropriate diagnosis is made in a high percentage of patients without laparotomy and resection. Most important in clinical practice is the differential diagnosis of focal nodular hyperplasia and hepatocellular adenoma because of the risk of rupture and bleeding in the latter. Cavernous haemangioma, the most common benign hepatic tumour, rarely needs treatment. The diagnosis of nodular regenerative hyperplasia is often missed and patients present with secondary complications and signs of portal hypertension that necessitate treatment. The main problem in angiomyolipoma is to distinguish it from malignant processes which do require treatment. Because of its clinical presentation, inflammatory pseudotumour is also sometimes confused with a malignant tumour. Therapeutic options are drug therapy or surgical resection. Benign haemangioendothelioma of the infant is rare but may cause life-threatening complications. Bile duct adenoma is an incidental finding that is not known to cause any symptoms whereas biliary cystadenoma is often symptomatic and may progress to cystadenocarcinoma and therefore needs resection.

Schlüsselwörter

Gutartige Lebertumoren - kavernöses Hämangion - hepatozelluläres Adenom - fokal noduläre Hyperplasie - noduläre regenerative Hyperplasie - Angiomyolipom - infammatorischer Pseudotumor - benignes Hämangioendothelion - Gallengangsadenom - biliäres Zystadenom

Key words

Benign hepatic tumours - cavernous haemangioma - hepatocellular adenoma - focal nodular hyperplasia - nodular regenerative hyperplasia - angiomyolipoma - inflammatory pseudotumour - benign haemangioendothelioma - bile duct adenoma - biliary cystadenoma

Full Text

References

1 Ros P R, Li K C. Benign liver tumors. Curr Probl Diagn Radiol. 1989; 18 125-155
2 Ito K, Honjo K, Fujita T. et al . Liver neoplasms: diagnostic pitfalls in cross-sectional imaging. Radiographics. 1996; 16 273-293
3 Gedaly R, Pomposelli J J, Pomfret E A. et al . Cavernous hemangioma of the liver: anatomic resection vs. enucleation. Arch Surg. 1999; 134 407-411
4 Belli L, De Carlis L, Beati C. et al . Surgical treatment of symptomatic giant hemangiomas of the liver. Surg Gynecol Obstet. 1992; 174 474-478
5 Saegusa T, Ito K, Oba N. et al . Enlargement of multiple cavernous hemangioma of the liver in association with pregnancy. Intern Med. 1995; 34 207-211
6 Conter R L, Longmire W P Jr. Recurrent hepatic hemangiomas. Possible association with estrogen therapy. Ann Surg. 1988; 207 115-119
7 Takahashi T, Kuwao S, Katagiri H. et al . Multiple liver hemangiomas enlargement during long-term steroid therapy for myasthenia gravis. Dig Dis Sci. 1998; 43 1553-1561
8 Baker E R, Manders E, Whitney C W. Growth of cavernous hemangioma with puberty. Clin Pediatr (Phila). 1985; 24 596-598
9 Brunt E M. Benign tumors of the liver. Clin Liver Dis. 2001; 5 1-15, v
10 Trotter J F, Everson G T. Benign focal lesions of the liver. Clin Liver Dis. 2001; 5 17-42, v
11 Pol B, Disdier P, Le T reut YP. et al . Inflammatory process complicating giant hemangioma of the liver: report of three cases. Liver Transpl Surg. 1998; 4 204-207
12 Hall G W. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol. 2001; 112 851-862
13 Hochwald S N, Blumgart L H. Giant hepatic hemangioma with Kasabach-Merritt syndrome: is the appropriate treatment enucleation or liver transplantation?. HPB Surg. 2000; 11 413-419
14 Bree R L, Schwab R E, Glazer G M. et al . The varied appearances of hepatic cavernous hemangiomas with sonography, computed tomography, magnetic resonance imaging and scintigraphy. Radiographics. 1987; 7 1153-1175
15 Perkins A B, Imam K, Smith W J. et al . Color and power Doppler sonography of liver hemangiomas: a dream unfulfilled?. J Clin Ultrasound. 2000; 28 159-165
16 Quinn S F, Benjamin G G. Hepatic cavernous hemangiomas: simple diagnostic sign with dynamic bolus CT. Radiology. 1992; 182 545-548
17 Soyer P, Dufresne A C, Somveille E. et al . Differentiation between hepatic cavernous hemangioma and malignant tumor with T2-weighted MRI: comparison of fast spin-echo and breathhold fast spin-echo pulse sequences. Clin Imaging. 1998; 22 200-210
18 Prakash R, Jena A, Behari V. et al . Technetium-99m red blood cell scintigraphy in diagnosis of hepatic hemangioma. Clin Nucl Med. 1987; 12 235-237
19 Kinnard M F, Alavi A, Rubin R A. et al . Nuclear imaging of solid hepatic masses. Semin Roentgenol. 1995; 30 375-395
20 Tung G A, Cronan J J. Percutaneous needle biopsy of hepatic cavernous hemangioma. J Clin Gastroenterol. 1993; 16 117-122
21 Nakaizumi A, Iishi H, Yamamoto R. et al . Diagnosis of hepatic cavernous hemangioma by fine needle aspiration biopsy under ultrasonic guidance. Gastrointest Radiol. 1990; 15 39-42
22 Farges O, Daradkeh S, Bismuth H. Cavernous hemangiomas of the liver: are there any indications for resection?. World J Surg. 1995; 19 19-24
23 Reddy K R, Kligerman S, Levi J. et al . Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg. 2001; 67 173-178
24 Hotokezaka M, Kojima M, Nakamura K. et al . Traumatic rupture of hepatic hemangioma. J Clin Gastroenterol. 1996; 23 69-71
25 Klompmaker I J, Sloof M J, van der Meer J. et al . Orthotopic liver transplantation in a patient with a giant cavernous hemangioma of the liver and Kasabach-Merritt syndrome. Transplantation. 1989; 48 149-151
26 Longeville J H, de la Hall P, Dolan P. et al . Treatment of a giant haemangioma of the liver with Kasabach-Merritt syndrome by orthotopic liver transplant a case report. HPB Surg. 1997; 10 159-162
27 Hanazaki K, Kajikawa S, Matsushita A. et al . Risk factors associated with intra-operative blood loss in hepatectomized patients with giant cavernous hemangioma of the liver. Hepatogastroenterology. 1999; 46 1089-1093
28 Srivastava D N, Gandhi D, Seith A. et al . Transcatheter arterial embolization in the treatment of symptomatic cavernous hemangiomas of the liver: a prospective study. Abdom Imaging. 2001; 26 510-514
29 Suzuki H, Nimura Y, Kamiya J. et al . Preoperative transcatheter arterial embolization for giant cavernous hemangioma of the liver with consumption coagulopathy. Am J Gastroenterol. 1997; 92 688-691
30 Tsai M K, Lee P H, Tung B S. et al . Experiences in surgical management of cavernous hemangioma of the liver. Hepatogastroenterology. 1995; 42 988-992
31 Bioulac-Sage P, Balabaud C, Wanless I R. Diagnosis of focal nodular hyperplasia: not so easy. Am J Surg Pathol. 2001; 25 1322-1325
32 Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology. 1977; 73 386-394
33 Mathieu D, Kobeiter H, Maison P. et al . Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology. 2000; 118 560-564
34 Weimann A, Mossinger M, Fronhoff K. et al . Pregnancy in women with observed focal nodular hyperplasia of the liver. Lancet. 1998; 351 1251-1252
35 Colle I, de Beeck B O, Hoorens A. et al . Multiple focal nodular hyperplasia. J Gastroenterol. 1998; 33 904-908
36 Sadowski D C, Lee S S, Wanless I R. et al . Progressive type of focal nodular hyperplasia characterized by multiple tumors and recurrence. Hepatology. 1995; 21 970-975
37 Schild H, Kreitner K F, Thelen M. et al . [Focal nodular hyperplasia of the liver in 930 patients]. ROFO Fortschr Geb Rontgenstr Nuklearmed. 1987; 147 612-618
38 Brunt E M, Flye M W. Infarction in focal nodular hyperplasia of the liver. A case report. Am J Clin Pathol. 1991; 95 503-506
39 Fukukura Y, Nakashima O, Kusaba A. et al . Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. J Hepatol. 1998; 29 470-475
40 Fischer H P, Lankes G. Morphologic correlation between liver epithelium and mesenchyme allows insight into histogenesis of focal nodular hyperplasia (FNH) of the liver. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991; 60 373-380
41 Gaffey M J, Iezzoni J C, Weiss L M. Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol. 1996; 148 1089-1096
42 Knowles D M, Wolff M. Focal nodular hyperplasia of the liver: a clinicopathologic study and review of the literature. Hum Pathol. 1976; 7 533-545
43 Cherqui D, Rahmouni A, Charlotte F. et al . Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology. 1995; 22 1674-1681
44 Harvey C J, Albrecht T. Ultrasound of focal liver lesions. Eur Radiol. 2001; 11 1578-1593
45 Golli M, Mathieu D, Anglade M C. et al . Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imaging. Radiology. 1993; 187 113-117
46 Uggowitzer M M, Kugler C, Mischinger H J. et al . Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver. J Ultrasound Med. 1999; 18 445-451; quiz 453-454
47 Ruppert-Kohlmayr A J, Uggowitzer M M, Kugler C. et al . Focal nodular hyperplasia and hepatocellular adenoma of the liver: differentiation with multiphasic helical CT. AJR Am J Roentgenol. 2001; 176 1493-1498
48 Kacl G M, Hagspiel K D, Marincek B. Focal nodular hyperplasia of the liver: serial MRI with Gd-DOTA, superparamagnetic iron oxide, and Gd-EOB-DTPA. Abdom Imaging. 1997; 22 264-267
49 Boulahdour H, Cherqui D, Charlotte F. et al . The hot spot hepatobiliary scan in focal nodular hyperplasia. J Nucl Med. 1993; 34 2105-2110
50 Foster J H. Benign liver tumours. Blumgart LH Surgery of the liver and biliary tract New York; Churchill Livingstone 1994 Vol. 2
51 Kerlin P, Davis G L, McGill D B. et al . Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology. 1983; 84 994-1002
52 Rooks J B, Ory H W, Ishak K G. et al . Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. Jama. 1979; 242 644-648
53 Nakao A, Sakagami K, Nakata Y. et al . Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. J Gastroenterol. 2000; 35 557-562
54 Labrune P, Trioche P, Duvaltier I. et al . Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr. 1997; 24 276-279
55 Baum J K, Bookstein J J, Holtz F. et al . Possible association between benign hepatomas and oral contraceptives. Lancet. 1973; 2 926-929
56 Kent D R, Nissen E D, Nissen S E. et al . Effect of pregnancy on liver tumor associated with oral contraceptives. Obstet Gynecol. 1978; 51 148-151
57 Scott L D, Katz A R, Duke J H. et al . Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. Jama. 1984; 251 1461-1463
58 Scott F R, el-Refaie A, More L. et al . Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma. Histopathology. 1996; 28 472-474
59 Ferrell L D. Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report. Am J Surg Pathol. 1993; 17 525-529
60 Mays E T, Christopherson W. Hepatic tumors induced by sex steroids. Semin Liver Dis. 1984; 4 147-157
61 Ribeiro A, Burgart L J, Nagorney D M. et al . Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg. 1998; 4 388-398
62 Golli M, Van Nhieu J T, Mathieu D. et al . Hepatocellular adenoma: color Doppler US and pathologic correlations. Radiology. 1994; 190 741-744
63 Grazioli L, Federle M P, Ichikawa T. et al . Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology. 2000; 216 395-402
64 Arrive L, Flejou J F, Vilgrain V. et al . Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology. 1994; 193 507-512
65 Herman P, Pugliese V, Machado M A. et al . Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg. 2000; 24 372-376
66 Shortell C K, Schwartz S I. Hepatic adenoma and focal nodular hyperplasia. Surg Gynecol Obstet. 1991; 173 426-431
67 Flowers B F, McBurney R P, Vera S R. Ruptured hepatic adenoma. A spectrum of presentation and treatment. Am Surg. 1990; 56 380-383
68 Belghiti J, Pateron D, Panis Y. et al . Resection of presumed benign liver tumours. Br J Surg. 1993; 80 380-383
69 Terkivatan T, de Wilt J H, de Man R A. et al . Treatment of ruptured hepatocellular adenoma. Br J Surg. 2001; 88 207-209
70 Ault G T, Wren S M, Ralls P W. et al . Selective management of hepatic adenomas. Am Surg. 1996; 62 825-829
71 Stolzel U, Tannapfel A, Wittekind C. et al . [Indications for liver biopsy in liver tumors]. Dtsch Med Wochenschr. 2000; 125 1041-1044
72 Tannapfel A, Wittekind C. [Preneoplasia of the liver. Definition-differential diagnosis-clinical consequences]. Pathologe. 2001; 22 399-406
73 Wanless I R. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. 1990; 11 787-797
74 Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol. 1990; 12 460-465
75 Zhou H, Wolff M, Pauleit D. et al . Multiple macroregenerative nodules in liver cirrhosis due to Budd-Chiari syndrome. Case reports and review of the literature. Hepatogastroenterology. 2000; 47 522-527
76 Dumortier J, Boillot O, Chevallier M. et al . Familial occurrence of nodular regenerative hyperplasia of the liver: a report on three families. Gut. 1999; 45 289-294
77 Haboubi N Y, Smith V J, Coyne J D. et al . Nodular regenerative hyperplasia of the liver in a non-treated patient with mesangiocapillary glomerulonephritis. Histopathology. 1991; 18 367-368
78 Shimamatsu K, Wanless I R. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology. 1997; 26 343-350
79 Washington K, Lane K L, Meyers W C. Nodular regenerative hyperplasia in partial hepatectomy specimens. Am J Surg Pathol. 1993; 17 1151-1158
80 Stromeyer F W, Ishak K G. Nodular transformation (nodular „regenerative” hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol. 1981; 12 60-71
81 Nzeako U C, Goodman Z D, Ishak K G. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. Am J Gastroenterol. 1996; 91 879-884
82 Loinaz C, Colina F, Musella M. et al . Orthotopic liver transplantation in 4 patients with portal hypertension and non-cirrhotic nodular liver. Hepatogastroenterology. 1998; 45 1787-1794
83 Dachman A H, Ros P R, Goodman Z D. et al . Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. AJR Am J Roentgenol. 1987; 148 717-722
84 Trauner M, Stepan K M, Resch M. et al . Diagnostic problems in nodular regenerative hyperplasia (nodular transformation) of the liver. Review of the literature and report of two cases. Z Gastroenterol. 1992; 30 187-194
85 Patriarche C, Pelletier G, Attali P. et al . Ultrasonography, angiography, computed tomography and magnetic resonance in nodular regenerative hyperplasia of the liver: report of a pseudo-tumoral case. Radiat Med. 1988; 6 111-114
86 Radomski J S, Chojnacki K A, Moritz M J. et al . Results of liver transplantation for nodular regenerative hyperplasia. Am Surg. 2000; 66 1067-1070
87 Dumortier J, Bizollon T, Scoazec J Y. et al . Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome. Scand J Gastroenterol. 2001; 36 417-422
88 Dachman A H, Lichtenstein J E, Friedman A C. et al . Infantile hemangioendothelioma of the liver: a radiologic-pathologic-clinical correlation. AJR Am J Roentgenol. 1983; 140 1091-1096
89 Diment J, Yurim O, Pappo O. Infantile Hemangioendothelioma of the Liver in an Adult. Arch Pathol Lab Med. 2001; 125 931-932
90 Selby D M, Stocker J T, Waclawiw M A. et al . Infantile hemangioendothelioma of the liver. Hepatology. 1994; 20 39-45
91 Braun P, Ducharme J C, Riopelle J L. et al . Hemangiomatosis of the liver in infants. J Pediatr Surg. 1975; 10 121-126
92 Dehner L P, Ishak K G. Vascular tumors of the liver in infants and children. A study of 30 cases and review of the literature. Arch Pathol. 1971; 92 101-111
93 Kaniklides C, Dimopoulos P A, Bajic D. Infantile hemangioendothelioma. A case report. Acta Radiol. 2000; 41 161-164
94 Keslar P J, Buck J L, Selby D M. From the archives of the AFIP. Infantile hemangioendothelioma of the liver revisited. Radiographics. 1993; 13 657-670
95 Sato M, Ishida H, Konno K. et al . Liver tumors in children and young patients: sonographic and color Doppler findings. Abdom Imaging. 2000; 25 596-601
96 Ezekowitz R A, Mulliken J B, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992; 326 1456-1463
97 Burrows P E, Rosenberg H C, Chuang H S. Diffuse hepatic hemangiomas: percutaneous transcatheter embolization with detachable silicone balloons. Radiology. 1985; 156 85-88
98 McHugh K, Burrows P E. Infantile hepatic hemangioendotheliomas: significance of portal venous and systemic collateral arterial supply. J Vasc Interv Radiol. 1992; 3 337-344
99 Hurvitz S A, Hurvitz C H, Sloninsky L. et al . Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol. 2000; 22 527-532
100 Enjolras O, Riche M C, Merland J J. et al . Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics. 1990; 85 491-498
101 Daller J A, Bueno J, Gutierrez J. et al . Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg. 1999; 34 98-105; discussion 105-106
102 Corbella F, Arico M, Podesta A F. et al . Infantile hepatic hemangioendothelioma treated by radiotherapy. Pediatr Radiol. 1983; 13 297-300
103 Nonomura A, Minato H, Kurumaya H. Angiomyolipoma predominantly composed of smooth muscle cells: problems in histological diagnosis. Histopathology. 1998; 33 20-27
104 Goodman Z D, Ishak K G. Angiomyolipomas of the liver. Am J Surg Pathol. 1984; 8 745-750
105 Nonomura A, Mizukami Y, Kadoya M. Angiomyolipoma of the liver: a collective review. J Gastroenterol. 1994; 29 95-105
106 Barnard M, Lajoie G. Angiomyolipoma: immunohistochemical and ultrastructural study of 14 cases. Ultrastruct Pathol. 2001; 25 21-29
107 Ahmadi T, Itai Y, Takahashi M. et al . Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging. 1998; 23 520-526
108 Yeh C N, Chen M F, Hung C F. et al . Angiomyolipoma of the liver. J Surg Oncol. 2001; 77 195-200
109 Coffin C M, Humphrey P A, Dehner L P. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol. 1998; 15 85-101
110 Gollapudi P, Chejfec G, Zarling E J. Spontaneous regression of hepatic pseudotumor. Am J Gastroenterol. 1992; 87 214-217
111 Cheuk W, Chan J K, Shek T W. et al . Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol. 2001; 25 721-731
112 Shek T W, Liu C L, Peh W C. et al . Intra-abdominal follicular dendritic cell tumour: a rare tumour in need of recognition. Histopathology. 1998; 33 465-470
113 Selves J, Meggetto F, Brousset P. et al . Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus. Am J Surg Pathol. 1996; 20 747-753
114 Zavaglia C, Barberis M, Gelosa F. et al . Inflammatory pseudotumour of the liver with malignant transformation. Report of two cases. Ital J Gastroenterol. 1996; 28 152-159
115 Shek T W, Ho F C, Ng I O. et al . Follicular dendritic cell tumor of the liver. Evidence for an Epstein-Barr virus-related clonal proliferation of follicular dendritic cells. Am J Surg Pathol. 1996; 20 313-324
116 Shek T W, Ng I O, Chan K W. Inflammatory pseudotumor of the liver. Report of four cases and review of the literature. Am J Surg Pathol. 1993; 17 231-238
117 Flisak M E, Budris D M, Olson M C. et al . Inflammatory pseudotumor of the liver: appearance on MRI. Clin Imaging. 1994; 18 1-3
118 Ishida H, Tatsuta M, Furukawa H. et al . Multiple inflammatory pseudotumors mimicking liver metastasis from colon cancer: report of a case. Surg Today. 2000; 30 530-533
119 Noi I, Loberant N, Cohen I. Inflammatory pseudotumor of the liver. Clin Imaging. 1994; 18 283-285
120 Jais P, Berger J F, Vissuzaine C. et al . Regression of inflammatory pseudotumor of the liver under conservative therapy. Dig Dis Sci. 1995; 40 752-756
121 Li G H, Li J Q, Lin Y Z. Inflammatory pseudotumor of the liver. J Surg Oncol. 1989; 42 244-248
122 Mangiante G L, Colombari R, Portuese A. et al . Inflammatory pseudotumor of the liver: case report and review of the literature. G Chir. 1997; 18 417-420
123 Karhunen P J. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol. 1986; 39 183-188
124 Bhathal P S, Hughes N R, Goodman Z D. The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol. 1996; 20 858-864
125 Govindarajan S, Peters R L. The bile duct adenoma. A lesion distinct from Meyenburg complex. Arch Pathol Lab Med. 1984; 108 922-924
126 Allaire G S, Rabin L, Ishak K G. et al . Bile duct adenoma. A study of 152 cases. Am J Surg Pathol. 1988; 12 708-715
127 Colombari R, Tsui W M. Biliary tumors of the liver. Semin Liver Dis. 1995; 15 402-413
128 Tajima T, Honda H, Kuroiwa T. et al . Radiologic features of intrahepatic bile duct adenoma: a look at the surface of the liver. J Comput Assist Tomogr. 1999; 23 690-695
129 Devaney K, Goodman Z D, Ishak K G. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol. 1994; 18 1078-1091
130 Wheeler D A, Edmondson H A. Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer. 1985; 56 1434-1445
131 Subramony C, Herrera G A, Turbat-Herrera E A. Hepatobiliary cystadenoma. A study of five cases with reference to histogenesis. Arch Pathol Lab Med. 1993; 117 1036-1042
132 Lewis W D, Jenkins R L, Rossi R L. et al . Surgical treatment of biliary cystadenoma. A report of 15 cases. Arch Surg. 1988; 123 563-568
133 Thomas J A, Scriven M W, Puntis M C. et al . Elevated serum CA 19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation. Cancer. 1992; 70 1841-1846
134 Choi B I, Lim J H, Han M C. et al . Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. Radiology. 1989; 171 57-61
135 Jenkins R L, Johnson L B, Lewis W D. Surgical approach to benign liver tumors. Semin Liver Dis. 1994; 14 178-189
136 Thommesen N. Biliary hamartomas (von Meyenburg complexes) in liver needle biopsies. Acta Pathol Microbiol Scand [A]. 1978; 86 93-99
137 Ohta W, Ushio H. Histological reconstruction of a Von Meyenburg’s complex on the liver surface. Endoscopy. 1984; 16 71-74
138 Ramos A, Torres V E, Holley K E. et al . The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch Pathol Lab Med. 1990; 114 180-184

Prof. Dr. T. Sauerbruch

Direktor der Medizinischen Klinik und Poliklinik I, Universitätsklinikum Bonn

Sigmund-Freud-Straße 25

53105 Bonn

Email: sauerbruch@uni-bonn.de